Product Details for: Adakveo

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous
100MG/10ML (10MG/ML)
Single-Dose Vial
351(a)
Adakveo
Rx
Proper Name
crizanlizumab-tmca
BLA Number
761128
Applicant
Novartis Pharmaceuticals Corporation
Original Approval Date
November 15, 2019
Date of First Licensure
RETURN TO SEARCH RESULTS